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eizures  triggered  by  fever,  qualiﬁed  as  febrile  seizures,
ave  been  for  decades  a  major  issue  for  children  in  devel-
ped  countries  and  more  so  in  resource-limited  settings.
pproximately  2--5%  of  children  are  affected  by  this  kind
f  seizure.  Many  studies  aimed  to  describe,  measure,  and
nalyze  several  hypotheses,  including  the  assessment  of  the
hysiopathological  mechanisms,  epidemiological  indicators,
are  management,  and  their  impact  on  their  later  neuro-
ogical  impairments,  such  as  epilepsy,  but  many  unknowns
emain.
In  this  issue  of  Jornal  de  Pediatria,  Dalbem  et  al.1 report
 population-based  cross-sectional  study  conducted  in  the
ity  of  Barra  do  Bugres  in  Brazil  to  assess  the  prevalence  of
enign  febrile  seizures  during  childhood.  The  main  outcome
as  a  prevalence  of  6.4/1000  habitants  (95%  conﬁdence
nterval  [CI],  3.8--10.1),  which  is  much  lower  than  the  results
eported  in  two  studies  also  performed  in  Brazil,  ranging
rom  13.9  to  16.0/1000,2,3 but  within  the  literature  range,
rom  3.5/1000  in  an  Arab  population4 to  17.0/1000  in  a
ural  north  American  population.5 One  of  the  strengths  of
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heir  study  was  that  almost  all  the  pediatric  population  in
he  study  area  was  included.  Several  hypotheses  were  dis-
ussed  to  explain  this  lower  result.  The  authors  reported
 selection  bias  and  a  lack  of  standardized  method,  which
id  not  allow  for  comparisons  between  studies.  In  addi-
ion  to  these  divergences,  it  is  admitted  that  interview
nd/or  questionnaire  surveys  have  lower  level  of  evidence,
specially  in  this  case.  Febrile  seizures  with  motor  manifes-
ations  were  the  most  identiﬁed,  leading  to  a  sub-selection
f  prevalent  cases,  generating  an  information  bias.  There-
ore,  the  selection  phase  of  the  present  study  used  a  history
f  febrile  seizure  to  identify  cases,  which  could  lead  to
 recall  bias.  Nevertheless,  these  studies  are  essential  to
ncrement  epidemiological  data.  Among  12  of  the  main
tudies  assessing  febrile  seizures  worldwide,  only  ﬁve  mea-
ured  the  prevalence;  patient  recruitment  methods  were
idely  different  and  there  was  no  homogeneity  regarding
ata  recorded.  These  variations  in  results  are  not  neces-
arily  an  irremediable  result  of  methodological  problems,
ut  more  frequently  than  expected  it  could  be  related  to
opulation  features  (age,  sex-ratio,  genetic  factors,  ori-
ins,  environmental  impacts,  etc.),  different  etiologies  (e.g.
eterogeneity  of  prevalence  of  infectious  diseases),  and/or
nknown  factors.  As  an  example  and  for  matter  of  compar-
son,  Yemadje  et  al.6 have  investigated  the  differences  in
revalence  of  epilepsy  in  tropical  regions.  Their  conclusions
orroborate  the  abovementioned  assumptions,  enhanced
y  the  stigmatization  of  people  with  epilepsy,  leading  to
n  underestimating  of  prevalence,  even  in  well-conducted
tudies.
er Editora Ltda. All rights reserved.
c
l
d
i
m
a
w
w
a
r
f
t
h
ﬁ
e
o
I
b
s
t
c
c
1
t
C
c
C
f
s
f
a
t
i
s
i
m
a
u
o
u
v
i
i
r
a
s
s
b
B
a
i
c
r
h
t
m
iEpidemiology  of  febrile  seizures  and  epilepsy  
A  febrile  seizure  is  a  convulsion  in  a  child  triggered  by
a  fever,  often  occurring  in  families,  and  most  often  in  chil-
dren  between  ages  of  9  months  and  5  years  according  to  the
National  Institutes  of  Health  (NIH).
Most  febrile  seizures  occur  in  the  ﬁrst  24  h  of  an  ill-
ness,  and  the  fever  has  an  unexpected  important  weight;
body  temperature  over  than  38.3 ◦C  increases  the  risk  fac-
tor  compare  to  lower  fever  than  38.3 ◦C.  Major  upper  airway
infections  such  as  ear  infections,  cold  or  viral  infections
represent  the  main  triggering  factors.  Most  often,  febrile
seizure  has  spontaneous  resolution  and  does  not  require
any  drug  treatment.  In  some  cases,  when  the  duration  of
the  seizure  exceeds  5  min,  infusion  of  lorazepam  or  midazo-
lam  can  avoid  convulsions.  If  there  is  no  resolution,  febrile
seizure  should  be  considered  as  status  epilepticus  and  the
management  should  follow  the  corresponding  medical  pro-
tocol.  In  this  regard,  phenobarbital  is  proposed  in  several
guidelines.  Farwell  et  al.7 reported  in  1990  that  a  treat-
ment  using  phenobarbital  (versus  placebo)  can  be  worse  in
the  care  of  febrile  seizures,  and  iatrogenic  cognitive  impair-
ments  have  been  observed.  This  outcome  could  be  explained
by  the  fundamental  pharmacological  effect  this  drug,  which
is  anticonvulsant  with  a  hypnotic  side  effect,  having  any
effect  on  the  fever.
The  most  frequent  evolution  is  no  more  seizures  ever  but
there  is  a  15--70%  risk  of  recurrence  in  the  ﬁrst  two  years
after  the  initial  febrile  seizure.  In  this  article,  only  one  case
(5.5%)  among  18  had  more  than  one  seizure;  and  another
one  (5.5%)  a  third  seizure.  Predictors  of  recurrence  are  com-
monly  age  at  onset  (higher  risk  for  child  who  experienced
febrile  seizure  before  18  months),  temperature  (low  fever
is  curiously  more  likely  linked  with  recurrence  than  high
fever),  and  a  positive  family  history  of  febrile  seizures.8,9
As  well  as  unprovoked  seizure  and  epilepsy,  provoked
seizures  are  quite  common  in  resource-limited  countries
under  tropical  areas  mainly  due  to  high  rates  of  central
nervous  system  (CNS)  infections  such  as  cerebral  malaria,
tuberculosis,  schistosomiasis,  HIV,  and  most  often  neuro-
cysticercosis  (NCC).  The  last  burden  has  been  frequently
associated  with  a  high  risk  of  epilepsy  impairment,  but
arising  an  afebrile  seizure.  It  is  noteworthy  that  febrile
seizure  should  be  distinguished  as  seizure  occurring  during
an  intracranial  infection  or  a  severe  metabolic  disturbance.
In  fact,  febrile  seizure  has  been  recognized  as  a  distinct  syn-
drome  separated  from  epilepsy.  The  International  League
Against  Epilepsy  (ILAE)  deﬁned  it  as  a  seizure  occurring  in
childhood  after  1 month  of  age  associated  with  a  febrile
illness  not  caused  by  a  CNS  infection,  without  previous
neonatal  seizures  or  previous  unprovoked  seizure,  and  not
meeting  the  criteria  for  other  acute  symptomatic  seizures.
Nevertheless,  although  a  divergence  of  origin  exists,  the  sig-
niﬁcant  link  between  both  affections  is  that  febrile  seizure
represents  an  important  risk  factor  for  developing  epilepsy.
Infectious  epilepsy  is  one  of  the  main  etiologies  described
in  several  studies.  Bhalla  et  al.10 described  in  2011  with
genetic,  brain  tumors,  and  head  trauma  cases,  that  cere-
bral  infections  have  a  signiﬁcant  weight  in  the  world  burden
of  epilepsy.  As  mentioned  above,  NCC  is  highly  associ-
ated  with  epilepsy  (30%  to  50%  of  all  epilepsy  in  endemic
zones)  and  South  America  is  deeply  impacted  by  this  public
health  issue,  as  well  as  Asia  and  Africa.  Mac  et  al.11 con-
ducted  a  literature  review  of  epidemiology,  etiology,  and
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linical  management  of  epilepsy  in  Asia,  which  was  pub-
ished  in  2007.  They  reported  that  main  causes  were
ominated  by  head  injury,  birth  trauma,  and  intracranial
nfections,  such  as  NCC  or  meningoencephalitis.  Further-
ore,  their  article  highlighted  the  lack  of  methodological
nd  powerful  studies  undertaken  in  those  countries,  which
ould  strengthen  the  body  of  evidence.  The  same  issues
ere  raised  in  a  sub-Saharan  Africa  conducted  by  Preux
nd  Druet-Cabanac,  published  in  2005,12 as  well  as  in  a
eview  and  update  by  Ba-Diop  et  al.  in  2014.13 The  main  risk
actors  for  epilepsy  in  that  area  of  the  world  were  family  his-
ory  of  seizures,  previous  febrile  seizures,  perinatal  trauma,
ead  injury,  and  CNS  infections,  such  as  NCC.  They  con-
rmed  that  febrile  seizures  were  commonly  associated  with
pileptic  seizures  among  the  pediatric  population  (6--38%
f  patients  with  epilepsy  had  a  history  of  febrile  seizures).
n  malaria-endemic  areas,  most  acute  seizures  are  caused
y  malaria,  but  whether  they  are  febrile  seizures  or  acute
ymptomatic  seizures  is  unclear.  Some  studies  have  assessed
he  link  between  epilepsy  and  cerebral  malaria  (CM)  as  a
onsequence  mostly  in  sub-Saharan  Africa.  In  Gabon,  a  case-
ontrol  study  observed  an  adjusted  odds  ratio  of  3.9  ([95%  CI,
.7--89.0],  p =  0.001)  to  develop  epilepsy  after  CM.  An  addi-
ional  risk  factor  was  febrile  convulsions  (aOR  =  9.2,  [95%
I,  4.0--21.1],  p  <  0.0001).14 An  exposed-non  exposed  study
arried  out  in  Mali  reported  a  relative  risk  of  14.3  ([95%
I,  1.6--132.0],  p  =  0.01)  adjusted  on  age  and  duration  of
ollow-up  to  develop  epilepsy  after  a CM.15 In  the  same  way,
eizures  triggered  by  malaria  infections  could  result  from
ever  only  (and  then  febrile  seizures),  but  convulsions  could
lso  occur  without  fever  in  malaria.16 The  authors  assumed
hat  interleukins  involved  in  inﬂammatory  reaction  could  be
nvolved  in  the  association  between  seizures  with  CM  and
equelar  epilepsy,  the  same  interleukins  that  are  involved
n  the  generation  of  febrile  seizures  and  epileptogenesis.
Assessing  the  epidemiology  of  illness  is  a  duty  to  further
edicine  knowledge;  however,  every  disease  can  have  vari-
tions  in  expression  and  etiology  due  to  many  known  and
nknown  factors.  This  postulate  emphasizes  the  importance
f  performing  studies  in  various  countries,  areas  (rural,
rban),  and  populations  to  collect  as  much  useful  and  rele-
ant  data  as  possible.  As  example  of  NCC,  which  is  endemic
n  many  regions  where  pigs  are  raised  including  Latin  Amer-
ca,  Africa,  and  Asia,  but  more  often  a  public  health  issue  in
esources-limited  settings  has  been  quite  assess.  For  now,
side  from  the  epidemiological  data  that  have  been  mea-
ured,  new  research  approaches  have  been  pointed  out,
uch  as  human  NCC,  which  offers  opportunity  to  understand
asic  mechanisms  of  seizures.17 To  focus  on  Latin  America,
razil  does  not  have  the  same  health  concerns  than  low
nd  middle-income  countries  (LMICs).  However,  neurolog-
cal  affections  such  as  epilepsy  are  not  insigniﬁcant.  In  a
ross-sectional  evaluation  of  neurological  diseases  in  a  rural
egion  of  Brazil,  the  most  common  groups  of  diseases  were
eadache  (32.2%)  and  epilepsy  (16.3%).18 But  in  contrast  of
ropical  and  sub-tropical  areas,  tropical  diseases  (including
alaria)  were  observed  in  a lower  proportion  than  expected
n  this  study,  even  though  Brazil  is  a country  that  present
ost  of  the  main  tropical  diseases  according  to  WHO.  Each
f  these  elements  highlights  the  difﬁculties  and  the  danger
o  generalize  a  result  in  all  situations,  mainly  due  to  ran-
om  and  unpredictable  events.  Performing  a  well-conducted
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tudy  requires  several  features  that  are  not  easily  reachable
nder  all  circumstances.  Bharucha  et  al.19 raised  method-
logical  difﬁculties  in  the  conduction  of  epidemiological
tudies  in  LMICs.  To  specify,  LMICs  face  regulatory  issues  and
ack  of  infrastructure  (lack  of  census  data,  lack  of  a  well-
eveloped  healthcare  system,  etc.),  with  a  wide  variety  of
ifferent  key  features  (perception  of  the  disease,  language,
igratory  patterns,  etc.)  depending  of  regional  conditions
nd  environmental  factors.  Medical  tools  frequently  used  in
rimary  studies,  such  as  the  questionnaire  to  identify  cases
n  the  Dalbem  study,  must  be  adapted  to  local  conditions  and
alidated  in  order  to  give  relevant  and  meaningful  data.  Only
ith  uniform  and  comparable  methodology,  primary  studies
an  provide  usable  data  for  systematic  reviews  and  meta-
nalyses.  These  recommendations  are  even  more  important
or  public  health  issues,  as  epilepsy  remains  one  of  the  major
eglected  diseases.  Indeed,  approximately  70  million  people
orldwide  may  have  epilepsy,  and  nearly  80%  of  them  live  in
esource-limited  countries.  In  2011,  Thurman  et  al.20 have
eﬁned  standards  (operational  deﬁnitions,  methods,  useful
nalysis,  etc.)  for  these  studies,  taking  into  account  the  vari-
bility  of  country  resources  and  different  study  purposes.
ach  study,  as  that  by  Dalbem  et  al.  in  Brazil,  should  be
upported  and  encouraged  to  provide  essential  information
eeded  for  extend  the  understanding  of  the  disease,  to  pro-
ote  prevention  and  effective  healthcare,  and  to  contribute
or  the  development  of  operational  support  programs.
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